Frontiers in Neurology,
Journal Year:
2021,
Volume and Issue:
12
Published: Aug. 16, 2021
While
current
therapeutic
strategies
for
people
living
with
human
immunodeficiency
virus
type
1
(HIV-1)
suppress
replication
peripherally,
viral
proteins
such
as
transactivator
of
transcription
(Tat)
enter
the
central
nervous
system
early
upon
infection
and
contribute
to
chronic
inflammatory
conditions
even
alongside
antiretroviral
treatment.
As
demand
grows
supplemental
combat
virus-associated
pathology
presenting
frequently
HIV-associated
neurocognitive
disorders
(HAND),
present
study
aimed
characterize
potential
utility
inhibiting
monoacylglycerol
lipase
(MAGL)
activity
increase
inhibitory
at
cannabinoid
receptor-type
receptors
through
upregulation
2-arachidonoylglycerol
(2-AG)
downregulation
its
degradation
into
proinflammatory
metabolite
arachidonic
acid
(AA).
The
MAGL
inhibitor
MJN110
significantly
reduced
intracellular
calcium
increased
dendritic
branching
complexity
in
Tat-treated
primary
frontal
cortex
neuron
cultures.
Chronic
administration
vivo
2-AG
levels
prefrontal
(PFC)
striatum
across
Tat(+)
Tat(-)
groups
restored
PFC
N-arachidonoylethanolamine
(AEA)
subjects.
Tat
expression
rate
reward-related
behavioral
task
acquisition
a
novel
discriminative
stimulus
learning
cognitive
flexibility
assay,
altered
reversal
specifically
mice
rates
indistinguishable
from
controls.
Collectively,
our
results
suggest
neuroprotective
role
inhibition
reducing
neuronal
hyperexcitability,
restoring
arborization
complexity,
mitigating
alterations
driven
by
associated
latent
HIV-1
infection.
Journal of Leukocyte Biology,
Journal Year:
2022,
Volume and Issue:
112(5), P. 1233 - 1243
Published: Sept. 8, 2022
Abstract
Macrophages
play
a
significant
role
in
HIV
infection
and
contribute
to
pathogenesis
of
comorbidities
as
well
establishment
the
viral
reservoir
people
living
with
HIV.
While
CD4+
T
cells
are
considered
main
targets
infection,
infected
macrophages
resist
cytopathic
effects
contributing
persistent
reservoir.
Furthermore,
activated
drive
inflammation
development
comorbidities,
including
HIV-associated
CNS
dysfunction.
Better
understanding
persistence,
can
lead
innovative
therapeutic
strategies
address
HIV-related
outcomes
In
October
2021,
National
Institute
Mental
Health
Ragon
MGH,
MIT,
Harvard
conducted
virtual
meeting
on
pathogenesis,
cure.
This
review
article
captures
key
highlights
from
this
provides
an
overview
interests
activities
various
NIH
institutes
involved
supporting
research
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Feb. 21, 2023
Abstract
We
have
recently
demonstrated
that
long-term
exposure
of
cigarette
smoke
condensate
(CSC)
to
HIV-uninfected
(U937)
and
-infected
(U1)
macrophages
induce
packaging
pro-inflammatory
molecules,
particularly
IL-1β,
in
extracellular
vesicles
(EVs).
Therefore,
we
hypothesize
EVs
derived
from
CSC-treated
CNS
cells
can
increase
their
IL-1β
levels
contributing
neuroinflammation.
To
test
this
hypothesis,
treated
the
U937
U1
differentiated
once
daily
with
CSC
(10
µg/ml)
for
7
days.
Then,
isolated
these
human
astrocytic
(SVGA)
neuronal
(SH-SY5Y)
absence
presence
CSC.
then
examined
protein
expression
oxidative
stress
related
proteins,
cytochrome
P450
2A6
(CYP2A6),
superoxide
dismutase-1
(SOD1),
catalase
(CAT).
observed
lower
compared
respective
EVs,
confirming
most
produced
are
packaged
into
EVs.
Further,
HIV-infected
uninfected
cells,
both
CSC,
were
SVGA
SH-SY5Y
cells.
These
treatments
showed
a
significant
However,
under
same
conditions,
CYP2A6,
SOD1,
only
markedly
altered.
findings
suggest
communicate
astrocytes
via
EVs-containing
HIV
non-HIV
setting
could
contribute
Frontiers in Neurology,
Journal Year:
2021,
Volume and Issue:
12
Published: Aug. 16, 2021
While
current
therapeutic
strategies
for
people
living
with
human
immunodeficiency
virus
type
1
(HIV-1)
suppress
replication
peripherally,
viral
proteins
such
as
transactivator
of
transcription
(Tat)
enter
the
central
nervous
system
early
upon
infection
and
contribute
to
chronic
inflammatory
conditions
even
alongside
antiretroviral
treatment.
As
demand
grows
supplemental
combat
virus-associated
pathology
presenting
frequently
HIV-associated
neurocognitive
disorders
(HAND),
present
study
aimed
characterize
potential
utility
inhibiting
monoacylglycerol
lipase
(MAGL)
activity
increase
inhibitory
at
cannabinoid
receptor-type
receptors
through
upregulation
2-arachidonoylglycerol
(2-AG)
downregulation
its
degradation
into
proinflammatory
metabolite
arachidonic
acid
(AA).
The
MAGL
inhibitor
MJN110
significantly
reduced
intracellular
calcium
increased
dendritic
branching
complexity
in
Tat-treated
primary
frontal
cortex
neuron
cultures.
Chronic
administration
vivo
2-AG
levels
prefrontal
(PFC)
striatum
across
Tat(+)
Tat(-)
groups
restored
PFC
N-arachidonoylethanolamine
(AEA)
subjects.
Tat
expression
rate
reward-related
behavioral
task
acquisition
a
novel
discriminative
stimulus
learning
cognitive
flexibility
assay,
altered
reversal
specifically
mice
rates
indistinguishable
from
controls.
Collectively,
our
results
suggest
neuroprotective
role
inhibition
reducing
neuronal
hyperexcitability,
restoring
arborization
complexity,
mitigating
alterations
driven
by
associated
latent
HIV-1
infection.